FDA Drug Promotion Oversight Under Scrutiny After Staff Reductions WASHINGTON – May 30, 2024 – Concerns are mounting over the FDA’s oversight of drug advertisement, specifically promotional practices. The inquiry arises in the wake of recent staff reductions within the Food and Drug Administration, particularly in the Office of prescription Drug Promotion (OPDP). Senator Durbin … Read more
Archyde The Looming Paradox in Cancer Treatment: ASCO 2024 Signals a Shift Towards Personalized, Yet Increasingly Unequal, Access Despite decades of progress, a troubling paradox is emerging in cancer care. While the American Society of Clinical Oncology (ASCO) 2024 meeting showcased remarkable advancements in targeted therapies and immunotherapies – particularly in breast cancer – these … Read more
Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was longer than usual on our side of the pond, thanks to a holiday — was relaxing and invigorating. Now, though, that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no … Read more
WASHINGTON — Robert F. Kennedy Jr. faces a White House deadline this week. His Make America Healthy Again commission must deliver a diagnosis of the nation’s epidemic of chronic disease. By summer’s end, it will need to offer solutions. In between comes the battle over priorities. Should the commission go all-in on obesity? Focusing on … Read more
Welcome to Lab Dish, a First Opinion column on regenerative medicine from Paul Knoepfler. Twenty years ago, the use of human embryonic stem cells in research was among the most fiercely debated topics at the always-crowded intersection of science and politics. As part of that, President George W. Bush restricted such research funding to existing … Read more
The Ripple Effect: How Trade Wars Impact Healthcare Costs the global economy is a complex web, and actions taken in one sector can have far-reaching consequences for others. This was starkly illustrated when President Trump imposed tariffs on goods from Canada, China, and Mexico in 2019, aiming to curb the flow of fentanyl and undocumented … Read more